INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
Go back to INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress| (NASDAQ: INMB) | Delayed: 2.44 +0.17 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 323,962 | |||||
| (NASDAQ: INMB) | Delayed: 2.44 +0.17 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 323,962 | |||||

